comparemela.com
Home
Live Updates
BioPorto A/S says 1Q revenue rises by 17%, boosted by strong sales growth for its NGAL test : comparemela.com
BioPorto A/S says 1Q revenue rises by 17%, boosted by strong sales growth for its NGAL test
BioPorto (NASDAQ COPENHAG:BIOPOR) A/S has announced that the strong performance of its flagship NGAL test drove revenue growth for the group in the first...
Related Keywords
Denmark
,
Danish
,
,
Drug Administration
,
Acute Kidney Injury
,
Breakthrough Device
,
Tony Pare
,
comparemela.com © 2020. All Rights Reserved.